305 related articles for article (PubMed ID: 17664267)
1. Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.
Mo Y; Quanquin NM; Vecino WH; Ranganathan UD; Tesfa L; Bourn W; Derbyshire KM; Letvin NL; Jacobs WR; Fennelly GJ
Infect Immun; 2007 Oct; 75(10):4804-16. PubMed ID: 17664267
[TBL] [Abstract][Full Text] [Related]
2. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
Cayabyab MJ; Hovav AH; Hsu T; Krivulka GR; Lifton MA; Gorgone DA; Fennelly GJ; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2006 Feb; 80(4):1645-52. PubMed ID: 16439521
[TBL] [Abstract][Full Text] [Related]
3. Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon.
Bourn WR; Jansen Y; Stutz H; Warren RM; Williamson AL; van Helden PD
Tuberculosis (Edinb); 2007 Nov; 87(6):481-8. PubMed ID: 17888739
[TBL] [Abstract][Full Text] [Related]
4. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
Hovav AH; Cayabyab MJ; Panas MW; Santra S; Greenland J; Geiben R; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2007 Jan; 81(1):74-83. PubMed ID: 17050608
[TBL] [Abstract][Full Text] [Related]
5. The development of a novel Mycobacterium-Escherichia coli shuttle vector system using pMyong2, a linear plasmid from Mycobacterium yongonense DSM 45126T.
Lee H; Kim BJ; Kim BR; Kook YH; Kim BJ
PLoS One; 2015; 10(3):e0122897. PubMed ID: 25822634
[TBL] [Abstract][Full Text] [Related]
6. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
[TBL] [Abstract][Full Text] [Related]
7. Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion.
Taylor N; Bahunde F; Thompson A; Yu JS; Jacobs WR; Letvin NL; Haynes BF; Lee S
Clin Vaccine Immunol; 2012 Sep; 19(9):1416-25. PubMed ID: 22787192
[TBL] [Abstract][Full Text] [Related]
8. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
9. A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycobacteria.
Harth G; Masleša-Galić S; Horwitz MA
Microbiology (Reading); 2004 Jul; 150(Pt 7):2143-2151. PubMed ID: 15256557
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
11. Plasmid transfer from Streptomyces to Mycobacterium smegmatis by spontaneous transformation.
Bhatt A; Kieser HM; Melton RE; Kieser T
Mol Microbiol; 2002 Jan; 43(1):135-46. PubMed ID: 11849542
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
13. Modification of the mycobacteriophage Ms6 attP core allows the integration of multiple vectors into different tRNAala T-loops in slow- and fast-growing mycobacteria.
Vultos TD; Méderlé I; Abadie V; Pimentel M; Moniz-Pereira J; Gicquel B; Reyrat JM; Winter N
BMC Mol Biol; 2006 Dec; 7():47. PubMed ID: 17173678
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity.
Shimada M; Yoshizaki S; Jounai N; Kondo A; Ichino M; Ryo A; Okuda K
Vaccine; 2010 Jul; 28(31):4920-7. PubMed ID: 20566393
[TBL] [Abstract][Full Text] [Related]
15. The porin MspA from Mycobacterium smegmatis improves growth of Mycobacterium bovis BCG.
Sharbati-Tehrani S; Meister B; Appel B; Lewin A
Int J Med Microbiol; 2004 Oct; 294(4):235-45. PubMed ID: 15532981
[TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
17. Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.
Yu JS; Peacock JW; Vanleeuwen S; Hsu T; Jacobs WR; Cayabyab MJ; Letvin NL; Frothingham R; Staats HF; Liao HX; Haynes BF
Clin Vaccine Immunol; 2006 Nov; 13(11):1204-11. PubMed ID: 16943347
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.
Snapper SB; Melton RE; Mustafa S; Kieser T; Jacobs WR
Mol Microbiol; 1990 Nov; 4(11):1911-9. PubMed ID: 2082148
[TBL] [Abstract][Full Text] [Related]
19. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine.
Fuerst TR; Stover CK; de la Cruz VF
Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119
[TBL] [Abstract][Full Text] [Related]
20. A novel differential expression system for gene modulation in Mycobacteria.
Fan XY; Ma H; Guo J; Li ZM; Cheng ZH; Guo SQ; Zhao GP
Plasmid; 2009 Jan; 61(1):39-46. PubMed ID: 18835406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
